Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Bayesian estimates of the incidence of rare cancers in Europe.

Botta L, Capocaccia R, Trama A, Herrmann C, Salmerón D, De Angelis R, Mallone S, Bidoli E, Marcos-Gragera R, Dudek-Godeau D, Gatta G, Cleries R; RARECAREnet Working group.

Cancer Epidemiol. 2018 Jun;54:95-100. doi: 10.1016/j.canep.2018.04.003. Epub 2018 Apr 21.

PMID:
29684802
2.

Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.

Guzzinati S, Virdone S, De Angelis R, Panato C, Buzzoni C, Capocaccia R, Francisci S, Gigli A, Zorzi M, Tagliabue G, Serraino D, Falcini F, Casella C, Russo AG, Stracci F, Caruso B, Michiara M, Caiazzo AL, Castaing M, Ferretti S, Mangone L, Rudisi G, Sensi F, Mazzoleni G, Pannozzo F, Tumino R, Fusco M, Ricci P, Gola G, Giacomin A, Tisano F, Candela G, Fanetti AC, Pala F, Sardo AS, Rugge M, Botta L, Maso LD.

BMC Cancer. 2018 Feb 9;18(1):169. doi: 10.1186/s12885-018-4053-y.

3.

Epidemiology of rare cancers and inequalities in oncologic outcomes.

Gatta G, Trama A, Capocaccia R; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30685-6. doi: 10.1016/j.ejso.2017.08.018. [Epub ahead of print]

PMID:
29032924
4.

[Health, public health, research, and participation. Considerations on the Italian ''Vaccination decree''].

Micheli A, Barbone F, Biggeri A, Capocaccia R, Davoli M, Pirastu R, Richiardi L, Traversa G, Forastiere F.

Epidemiol Prev. 2017 May-Aug;41(3-4):149-151. doi: 10.19191/EP17.3-4.P149.039. Italian. No abstract available.

PMID:
28929702
5.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group.

Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433.

PMID:
28687376
6.

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group.

Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.

PMID:
28410490
7.

Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material.

Crocetti E, Bossard N, Uhry Z, Roche L, Rossi S, Capocaccia R, Faivre J; GRELL EUROCARE-5 Working Group.

Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S3-S8. doi: 10.1097/CEJ.0000000000000300.

PMID:
28005599
8.

Data quality in rare cancers registration: the report of the RARECARE data quality study.

Trama A, Marcos-Gragera R, Sánchez Pérez MJ, van der Zwan JM, Ardanaz E, Bouchardy C, Melchor JM, Martinez C, Capocaccia R, Vicentini M, Siesling S, Gatta G; RARECARE working group contributing to the data quality study.

Tumori. 2017 Jan 21;103(1):22-32. doi: 10.5301/tj.5000559. Epub 2016 Oct 3.

PMID:
27716878
9.

Estimates of prostate cancer burden in Italy.

Capocaccia R, Foschi R, Zucchetto A, Valdagni R, Nicolai N, Maffezzini M, Gatta G.

Cancer Epidemiol. 2016 Feb;40:166-72. doi: 10.1016/j.canep.2015.12.004. Epub 2015 Dec 29.

PMID:
26771313
10.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group.

Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23.

PMID:
26686258
11.

Mortality in Italian veterans deployed in Bosnia-Herzegovina and Kosovo.

Capocaccia R, Biselli R, Ruggeri R, Tesei C, Grande E, Martina L, Rocchetti A, Salmaso S, Caldora M, Francisci S.

Eur J Public Health. 2016 Aug;26(4):712-7. doi: 10.1093/eurpub/ckv217. Epub 2015 Dec 3.

PMID:
26635013
12.

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.

Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2169-2178. doi: 10.1016/j.ejca.2015.07.034. Epub 2015 Sep 26.

PMID:
26421820
13.

The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.

Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, Santaquilani M, Trama A, Allemani C, Belot A, Buzzoni C, Lorez M, De Angelis R; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2104-2119. doi: 10.1016/j.ejca.2015.08.001. Epub 2015 Sep 26.

PMID:
26421815
14.

Biological monitoring of Italian soldiers deployed in Iraq. Results of the SIGNUM project.

Bolognesi C, Migliore L, Lista F, Caroli S, Patriarca M, De Angelis R, Capocaccia R, Amadori S, Pulliero A, Balia C, Colognato R, La Gioia V, Bonassi S, Izzotti A.

Int J Hyg Environ Health. 2016 Jan;219(1):24-32. doi: 10.1016/j.ijheh.2015.08.001. Epub 2015 Aug 4.

PMID:
26306831
15.

Rare cancers in The Netherlands: a population-based study.

van der Zwan JM, van Dijk BAC, Visser O, van Krieken HJHJM, Capocaccia R, Siesling S.

Eur J Cancer Prev. 2018 Jul;27(4):384-390. doi: 10.1097/CEJ.0000000000000166.

PMID:
25969132
16.

Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data.

Capocaccia R, Gatta G, Dal Maso L.

Ann Oncol. 2015 Jun;26(6):1263-8. doi: 10.1093/annonc/mdv131. Epub 2015 Mar 3.

PMID:
25735314
17.

Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study.

Tumino R, Minicozzi P, Frasca G, Allemani C, Crocetti E, Ferretti S, Giacomin A, Natali M, Mangone L, Falcini F, Capocaccia R, Sant M.

Cancer Epidemiol. 2015 Jun;39(3):424-9. doi: 10.1016/j.canep.2015.01.016. Epub 2015 Feb 28.

PMID:
25735220
18.

Is long-term cancer survivors' quality of life comparable to that of the general population? An italian study.

Annunziata MA, Muzzatti B, Giovannini L, Romito F, Cormio C, Mattioli V, Barberio D, Abate V, De Falco F, Mirabella F, Picardi A, Capocaccia R, Tirelli U.

Support Care Cancer. 2015 Sep;23(9):2663-8. doi: 10.1007/s00520-015-2628-6. Epub 2015 Feb 3.

PMID:
25646617
19.

Italian regional health system structure and expected cancer survival.

Vercelli M, Lillini R, Quaglia A, Capocaccia R; SEIH (Socio-Economic Indicators and Health) Working Group & AIRTUM contributors.

Tumori. 2014 Jul-Aug;100(4):386-98. doi: 10.1700/1636.17892.

PMID:
25296587
20.

Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.

Dal Maso L, Guzzinati S, Buzzoni C, Capocaccia R, Serraino D, Caldarella A, Dei Tos AP, Falcini F, Autelitano M, Masanotti G, Ferretti S, Tisano F, Tirelli U, Crocetti E, De Angelis R; AIRTUM Working group.

Ann Oncol. 2014 Nov;25(11):2251-60. doi: 10.1093/annonc/mdu383. Epub 2014 Aug 22.

21.

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group.

Lancet Oncol. 2014 Jan;15(1):23-34. doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5.

PMID:
24314615
22.

Cancer burden estimates and forecasts: uses and cautions.

Gatta G, Rossi S, Capocaccia R.

Tumori. 2013 May-Jun;99(3):439-43. doi: 10.1700/1334.14809.

PMID:
24158074
23.

Estimates of cancer burden in Italy.

Rossi S, Crocetti E, Capocaccia R, Gatta G; AIRTUM Working Group.

Tumori. 2013 May-Jun;99(3):416-24. doi: 10.1700/1334.14807.

PMID:
24158072
24.

Estimates of cancer burden in Sicily.

Tumino R, Capocaccia R, Traina A, Madeddu A, Contrino ML, Zigon G.

Tumori. 2013 May-Jun;99(3):399-407. doi: 10.1700/1334.14805.

PMID:
24158070
25.

Estimates of cancer burden in Basilicata and Calabria.

Galasso R, Capocaccia R, Del Riccio L, Viviano L, Matera R, Rossi S.

Tumori. 2013 May-Jun;99(3):390-8. doi: 10.1700/1334.14804.

PMID:
24158069
26.

Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.

Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG.

Cancer Epidemiol. 2013 Dec;37(6):850-6. doi: 10.1016/j.canep.2013.08.001. Epub 2013 Sep 16.

PMID:
24050903
27.

Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.

Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P, Lombardo C, Aareleid T, Ardanaz E, Bielska-Lasota M, Bolick S, Cress R, Elferink M, Fulton JP, Galceran J, Gózdz S, Hakulinen T, Primic-Zakelj M, Rachtan J, Diba CS, Sánchez MJ, Schymura MJ, Shen T, Tagliabue G, Tumino R, Vercelli M, Wolf HJ, Wu XC, Coleman MP.

BMJ Open. 2013 Sep 10;3(9):e003055. doi: 10.1136/bmjopen-2013-003055. Erratum in: BMJ Open. 2013;3(10):e003055corr1.

28.

Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.

Gatta G, Trama A, Capocaccia R.

J Natl Cancer Inst Monogr. 2013;2013(46):79-87. doi: 10.1093/jncimonographs/lgt004.

PMID:
23962511
29.

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.

Crocetti E, De Angelis R, Buzzoni C, Mariotto A, Storm H, Colonna M, Zanetti R, Serraino D, Michiara M, Cirilli C, Iannelli A, Mazzoleni G, Sechi O, Sanoja Gonzalez ME, Guzzinati S, Capocaccia R, Dal Maso L; AIRTUM Working group.

Br J Cancer. 2013 Jul 9;109(1):219-28. doi: 10.1038/bjc.2013.311. Epub 2013 Jun 25.

30.

Childhood (0-19 years) cancer mortality in Italy, 1970-2008.

Gatta G, Caldora M, Galati F, Capocaccia R.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):228-33. English, Italian. No abstract available.

31.

Cancer prevalence estimates in Europe at the beginning of 2000.

Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R; EUROCARE Working Group.

Ann Oncol. 2013 Jun;24(6):1660-6. doi: 10.1093/annonc/mdt030. Epub 2013 Apr 3.

PMID:
23553062
32.

Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.

Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Bertario L, Genuardi M, Lucci Cordisco E, Tibiletti MG, Di Gregorio C, Andriulli A, Ponz de Leon M; AIFEG.

Dig Liver Dis. 2013 Jul;45(7):606-11. doi: 10.1016/j.dld.2012.12.018. Epub 2013 Feb 15.

PMID:
23415580
33.

Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.

Gatta G, Rossi S, Foschi R, Trama A, Marcos-Gragera R, Pastore G, Peris-Bonet R, Stiller C, Capocaccia R; EUROCARE Working Group.

Haematologica. 2013 May;98(5):744-52. doi: 10.3324/haematol.2012.071597. Epub 2013 Feb 12.

34.

Looking at differences in stage and treatment of colorectal cancers across Italy: a EUROCARE-5 high resolution study.

Minicozzi P, Caldarella A, Giacomin A, Ponz de Leon M, Cesaraccio R, Falcini F, Fusco M, Iachetta F, Pellegri C, Tumino R, Capocaccia R, Sant M.

Tumori. 2012 Nov;98(6):671-7. doi: 10.1700/1217.13488.

PMID:
23389351
35.

The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.

Trama A, Mallone S, Ferretti S, Meduri F, Capocaccia R, Gatta G; RITA working group.

Tumori. 2012 Sep-Oct;98(5):550-8. doi: 10.1700/1190.13194.

PMID:
23235748
36.

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

Maynadié M, De Angelis R, Marcos-Gragera R, Visser O, Allemani C, Tereanu C, Capocaccia R, Giacomin A, Lutz JM, Martos C, Sankila R, Johannesen TB, Simonetti A, Sant M; HAEMACARE Working Group.

Haematologica. 2013 Feb;98(2):230-8. doi: 10.3324/haematol.2012.064014. Epub 2012 Sep 14.

37.

Use of SERTS (Socio-Economic, health Resources and Technologic Supplies) models to estimate cancer survival at provincial geographical level.

Vercelli M, Lillini R, Capocaccia R, Quaglia A; Socio-Economic Indicators and Health Working Group; AIRTUM Contributors.

Cancer Epidemiol. 2012 Dec;36(6):566-74. doi: 10.1016/j.canep.2012.07.010. Epub 2012 Aug 17.

PMID:
22906484
38.

Cancer prevalence in Italy: an analysis of geographic variability.

Guzzinati S, Buzzoni C, De Angelis R, Rosso S, Tagliabue G, Vercelli M, Pannozzo F, Mangone L, Piffer S, Fusco M, Giacomin A, Traina A, Capocaccia R, Dal Maso L, Crocetti E; AIRTUM working group.

Cancer Causes Control. 2012 Sep;23(9):1497-510. doi: 10.1007/s10552-012-0025-8. Epub 2012 Jul 21.

PMID:
22821425
39.

Regional inequalities in cancer care persist in Italy and can influence survival.

Sant M, Minicozzi P, Allemani C, Cirilli C, Federico M, Capocaccia R, Budroni M, Candela P, Crocetti E, Falcini F, Ferretti S, Fusco M, Giacomin A, La Rosa F, Mangone L, Natali M, Leon MP, Traina A, Tumino R, Zambon P.

Cancer Epidemiol. 2012 Dec;36(6):541-7. doi: 10.1016/j.canep.2012.06.006. Epub 2012 Jul 6.

PMID:
22770694
40.

Differences in stage and treatment of breast cancer across Italy point to inequalities in access to and availability of proper care.

Minicozzi P, Cirilli C, Federico M, Capocaccia R, Budroni M, Candela P, Falcini F, Fusco M, Giacomin A, La Rosa F, Traina A, Tumino R, Sant M.

Tumori. 2012 Mar-Apr;98(2):204-9. doi: 10.1700/1088.11930.

PMID:
22677985
41.

Effect of screening on deaths from cervical cancer in Sweden.

Arbyn M, Weiderpass E, Capocaccia R.

BMJ. 2012 Mar 1;344:e804. doi: 10.1136/bmj.e804. No abstract available.

PMID:
22381675
42.

Embryonal cancers in Europe.

Gatta G, Ferrari A, Stiller CA, Pastore G, Bisogno G, Trama A, Capocaccia R; RARECARE Working Group.

Eur J Cancer. 2012 Jul;48(10):1425-33. doi: 10.1016/j.ejca.2011.12.027. Epub 2012 Feb 20.

PMID:
22357215
43.

Invasive extramammary Paget's disease and the risk for secondary tumours in Europe.

van der Zwan JM, Siesling S, Blokx WA, Pierie JP, Capocaccia R.

Eur J Surg Oncol. 2012 Mar;38(3):214-21. doi: 10.1016/j.ejso.2011.12.008. Epub 2012 Jan 14.

PMID:
22244907
44.

Rare cancers of the head and neck area in Europe.

Van Dijk BA, Gatta G, Capocaccia R, Pierannunzio D, Strojan P, Licitra L; RARECARE Working Group.

Eur J Cancer. 2012 Apr;48(6):783-96. doi: 10.1016/j.ejca.2011.08.021. Epub 2011 Nov 1.

PMID:
22051735
45.

Rare cancers are not so rare: the rare cancer burden in Europe.

Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE working group.

Eur J Cancer. 2011 Nov;47(17):2493-511. doi: 10.1016/j.ejca.2011.08.008. Epub 2011 Oct 25.

PMID:
22033323
46.

Use of socio-economic factors and healthcare resources to estimate cancer survival in European countries with partial national cancer registration.

Lillini R, Vercelli M, Quaglia A, Micheli A, Capocaccia R.

Tumori. 2011 May-Jun;97(3):265-74. doi: 10.1700/912.10020.

PMID:
21789001
47.

Rebuttal to editorial saying cancer survival statistics are misleading.

Coleman MP, Rachet B, Woods L, Berrino F, Butler J, Capocaccia R, Dickman P, Gavin A, Giorgi R, Hamilton W, Lambert P, Peake MD, Perme MP, Stare J, Vedstedt P.

BMJ. 2011 Jul 5;343:d4214. doi: 10.1136/bmj.d4214. No abstract available.

PMID:
21729985
48.

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.

Marcos-Gragera R, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Maynadie M, Luminari S, Ferretti S, Johannesen TB, Sankila R, Karjalainen-Lindsberg ML, Simonetti A, Martos MC, Raphaël M, Giraldo P, Sant M; HAEMACARE Working Group.

Haematologica. 2011 May;96(5):720-8. doi: 10.3324/haematol.2010.034264. Epub 2011 Feb 17.

49.

The burden of rare cancers in Europe.

Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group.

Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Review.

PMID:
20824452
50.

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.

Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F; HAEMACARE Working Group.

Blood. 2010 Nov 11;116(19):3724-34. doi: 10.1182/blood-2010-05-282632. Epub 2010 Jul 27. Erratum in: Blood. 2011 Mar 24;117(12):3477.

Supplemental Content

Loading ...
Support Center